166 related articles for article (PubMed ID: 30607019)
1. Recurrent PDGFRB mutations in unicentric Castleman disease.
Li Z; Lan X; Li C; Zhang Y; Wang Y; Xue W; Lu L; Jin M; Zhou Z; Wang X; Li L; Zhang L; Li X; Fu X; Sun Z; Wu J; Zhang X; Yu H; Nan F; Chang Y; Yan J; Wu X; Wang G; Zhang D; Zhang Y; Young KH; Zhang M
Leukemia; 2019 Apr; 33(4):1035-1038. PubMed ID: 30607019
[No Abstract] [Full Text] [Related]
2. Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
Wang S; Wang R; Shang P; Zhu X; Chen X; Zhang G; Wang M
J Invest Dermatol; 2024 Mar; 144(3):585-592.e1. PubMed ID: 37839777
[TBL] [Abstract][Full Text] [Related]
3. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease.
Chang KC; Wang YC; Hung LY; Huang WT; Tsou JH; M Jones D; Song HL; Yeh YM; Kao LY; Medeiros LJ
Mod Pathol; 2014 Jun; 27(6):823-31. PubMed ID: 24201121
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease.
You L; Lin Q; Zhao J; Shi F; Young KH; Qian W
Br J Haematol; 2020 Mar; 188(5):e64-e67. PubMed ID: 31863597
[No Abstract] [Full Text] [Related]
5. Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease.
Goodman AM; Jeong AR; Phillips A; Wang HY; Sokol ES; Cohen PR; Sicklick J; Fajgenbaum DC; Kurzrock R
Eur J Haematol; 2021 Dec; 107(6):642-649. PubMed ID: 34431136
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
7. Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.
Takenouchi T; Yamaguchi Y; Tanikawa A; Kosaki R; Okano H; Kosaki K
J Pediatr; 2015 Feb; 166(2):483-6. PubMed ID: 25454926
[TBL] [Abstract][Full Text] [Related]
8. Myofibromatosis presenting as reticulated vascular changes and subcutaneous atrophy in a patient with somatic mosaicism of PDGFRB mutation.
Zhong CS; Song H; Weiss A; Tan WH; Coury S; Huang JT
Br J Dermatol; 2018 Dec; 179(6):1408-1409. PubMed ID: 29999524
[No Abstract] [Full Text] [Related]
9. Pathology of Castleman Disease.
Wu D; Lim MS; Jaffe ES
Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
[TBL] [Abstract][Full Text] [Related]
10. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
[TBL] [Abstract][Full Text] [Related]
11. Unicentric Castleman Disease.
Wong RSM
Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
[TBL] [Abstract][Full Text] [Related]
12. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
Nicolas G; Pottier C; Maltête D; Coutant S; Rovelet-Lecrux A; Legallic S; Rousseau S; Vaschalde Y; Guyant-Maréchal L; Augustin J; Martinaud O; Defebvre L; Krystkowiak P; Pariente J; Clanet M; Labauge P; Ayrignac X; Lefaucheur R; Le Ber I; Frébourg T; Hannequin D; Campion D
Neurology; 2013 Jan; 80(2):181-7. PubMed ID: 23255827
[TBL] [Abstract][Full Text] [Related]
14. A novel PDGFRB sequence variant in a family with a mild form of primary familial brain calcification: a case report and a review of the literature.
Mathorne SW; Sørensen K; Fagerberg C; Bode M; Hertz JM
BMC Neurol; 2019 Apr; 19(1):60. PubMed ID: 30979360
[TBL] [Abstract][Full Text] [Related]
15. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
[TBL] [Abstract][Full Text] [Related]
16. Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Abid MB; Peck R; Abid MA; Al-Sakkaf W; Zhang Y; Dunnill GS; Staines K; Sequeiros IM; Lowry L
Hematol Oncol; 2018 Feb; 36(1):320-323. PubMed ID: 28401573
[TBL] [Abstract][Full Text] [Related]
17. Unicentric subcutaneous Castleman disease in the upper extremity: a case study and review of the literature.
Fuse M; Koike T; Nakanishi T; Tanaka T; Namura T; Moritani S; Fujimoto N
Eur J Dermatol; 2020 Oct; 30(5):617-618. PubMed ID: 33185536
[No Abstract] [Full Text] [Related]
18. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
[TBL] [Abstract][Full Text] [Related]
19. A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N
Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537
[TBL] [Abstract][Full Text] [Related]
20. Odontogenic myxomas lack PDGFRB mutations reported in myofibromas.
de Siqueira EC; de Sousa SF; Carlos R; de Andrade BAB; Romañach MJ; Gomez RS; Gomes CC
J Oral Pathol Med; 2020 Mar; 49(3):278-283. PubMed ID: 32050038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]